StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3047% below fair value
$1.32−0.04 (-2.94%)

Close on Nov 16, 2026Market cap $6.07MP/E –Yield –

Biomerica gross margin

Gross margin is gross profit as a percentage of revenue.

Biomerica's gross margin for the twelve months ending Aug 31, 2026 was 0.9%. For fiscal 2026 it was 8.1%, against 9.4% the year before. The highest annual figure on record is 37.8% in fiscal 2012.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026May 31, 20268.1%−1.2
FY2025May 31, 20259.4%−1.9
FY2024May 31, 202411.3%+2.9
FY2023May 31, 20238.4%−7.4
FY2022May 31, 202215.8%+10.7
FY2021May 31, 20215.1%−20.9
FY2020May 31, 202026.0%+1.1
FY2019May 31, 201924.8%−6.7
FY2018May 31, 201831.5%−3.4
FY2017May 31, 201734.9%+5.3
FY2016May 31, 201629.7%−1.4
FY2015May 31, 201531.1%−1.5
FY2014May 31, 201432.6%−4.9
FY2013May 31, 201337.5%−0.3
FY2012May 31, 201237.8%+6.6
FY2011May 31, 201131.1%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ3 2026Aug 31, 20268.1%−22.6
Q4 FY2026CQ2 2026May 31, 2026-8.1%+24.5
Q3 FY2026CQ1 2026Feb 28, 2026-4.5%−6.2
Q2 FY2026CQ4 2025Nov 30, 20254.2%−22.5
Q1 FY2026CQ3 2025Aug 31, 202530.7%+14.7
Q4 FY2025CQ2 2025May 31, 2025-32.6%−34.4
Q3 FY2025CQ1 2025Feb 28, 20251.7%+16.3
Q2 FY2025CQ4 2024Nov 30, 202426.7%+6.0
Q1 FY2025CQ3 2024Aug 31, 202416.0%−8.1
Q4 FY2024CQ2 2024May 31, 20241.8%−0.8
Q3 FY2024CQ1 2024Feb 29, 2024-14.7%−25.5
Q2 FY2024CQ4 2023Nov 30, 202320.7%−3.0
Q1 FY2024CQ3 2023Aug 31, 202324.1%+27.4
Q4 FY2023CQ2 2023May 31, 20232.6%−9.1
Q3 FY2023CQ1 2023Feb 28, 202310.8%−11.0
Q2 FY2023CQ4 2022Nov 30, 202223.8%+7.1
Q1 FY2023CQ3 2022Aug 31, 2022-3.4%+3.7
Q4 FY2022CQ2 2022May 31, 202211.7%+10.5
Q3 FY2022CQ1 2022Feb 28, 202221.8%+23.9
Q2 FY2022CQ4 2021Nov 30, 202116.6%−5.9
Q1 FY2022CQ3 2021Aug 31, 2021-7.1%−17.4
Q4 FY2021CQ2 2021May 31, 20211.2%−24.1
Q3 FY2021CQ1 2021Feb 28, 2021-2.0%−20.0
Q2 FY2021CQ4 2020Nov 30, 202022.5%−6.9
Q1 FY2021CQ3 2020Aug 31, 202010.3%−20.4
Q4 FY2020CQ2 2020May 31, 202025.3%+9.8
Q3 FY2020CQ1 2020Feb 29, 202018.0%−11.0
Q2 FY2020CQ4 2019Nov 30, 201929.4%+2.2
Q1 FY2020CQ3 2019Aug 31, 201930.8%+4.3
Q4 FY2019CQ2 2019May 31, 201915.5%−8.2
Q3 FY2019CQ1 2019Feb 28, 201929.0%−4.8
Q2 FY2019CQ4 2018Nov 30, 201827.2%−4.2
Q1 FY2019CQ3 2018Aug 31, 201826.5%−9.1
Q4 FY2018CQ2 2018May 31, 201823.7%−6.5
Q3 FY2018CQ1 2018Feb 28, 201833.8%+3.9
Q2 FY2018CQ4 2017Nov 30, 201731.4%−7.5
Q1 FY2018CQ3 2017Aug 31, 201735.6%–
Q4 FY2017CQ2 2017May 31, 201730.3%–
Q3 FY2017CQ1 2017Feb 28, 201730.0%–
Q2 FY2017CQ4 2016Nov 30, 201638.9%–

More Biomerica figures

See a number that looks wrong?